The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium
Open accessAbstract
Pulmonary gene delivery is thought to play an important role in treating genetically related diseases and may induce immunity towards pathogens entering the body via the airways. In this study we prepared poly (d,l-lactide-co-glycolide) (PLGA) nanoparticles bearing polyethyleneimine (PEI) on their surface and characterized them for their potential in serving as non-viral gene carriers to the pulmonary epithelium. Particles that were synthesized at different PLGA–PEI ratios and loaded with DNA in several PEI–DNA ratios, exhibited narrow size distribution in all formulations, with mean particle sizes ranging between 207 and 231 nm. Zeta potential was strongly positive (above 30 mV) for all the PEI–DNA ratios examined and the loading efficiency exceeded 99% for all formulations. Internalization of the DNA-loaded PLGA–PEI nanoparticles was studied in the human airway submucosal epithelial cell line, Calu-3, and DNA was detected in the endo-lysosomal compartment 6 h after particles were applied. Cytotoxicity of these nanoparticles was dependent on the PEI–DNA ratio and best cell viability was achieved by PEI–DNA ratios 1:1 and 0.5:1. These findings demonstrate that PLGA–PEI nanoparticles are a potential new delivery system to carry genes to the lung epithelium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Cationic Polymer Based Gene Delivery Systems
De Smedt, S. C., Demeester, J., & Hennink, W. E. (2000) · Pharmaceutical Research · doi:10.1023/a:1007548826495 · Cited by 884
Design and gene delivery activity of modified polyethylenimines
Kircheis, R., Wightman, L., & Wagner, E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00202-2 · Cited by 651
Characterization of commercially available and synthesized polyethylenimines for gene delivery
von Harpe, A., Petersen, H., Li, Y., & Kissel, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00317-5 · Cited by 519
Cationic microparticles: A potent delivery system for DNA vaccines
Singh, M., Briones, M., Ott, G., & O'Hagan, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.811 · Cited by 489
Key issues in non-viral gene delivery
Pouton, C. W., & Seymour, L. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00048-9 · Cited by 440
In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
Zauner, W., Farrow, N. A., & Haines, A. M. R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00358-8 · Cited by 411
Recent advances in pulmonary drug delivery using large, porous inhaled particles
Edwards, D. A., Ben-Jebria, A., & Langer, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.2.379 · Cited by 341
Perez, C., Sanchez, A., Putnam, D., Ting, D., Langer, R., & Alonso, M. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00397-2 · Cited by 313
Pouton, C. W., & Seymour, L. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00133-2 · Cited by 291
Florea, B. I., Meaney, C., Junginger, H. E., & Borchard, G. (2002) · AAPS PharmSci · doi:10.1208/ps040312 · Cited by 243
Self-citationWalter, E., Dreher, D., Kok, M., Thiele, L., Kiama, S. G., Gehr, P., & Merkle, H. P. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00413-8 · Cited by 230
Uptake of poly(D,L‐lactic‐co‐glycolic acid) microspheres by antigen‐presenting cells in vivo
Newman, K. D., Elamanchili, P., Kwon, G. S., & Samuel, J. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.10019 · Cited by 195
Densmore, C. L., Orson, F. M., Xu, B., Kinsey, B. M., Waldrep, J. C., Hua, P., Bhogal, B., & Knight, V. (2000) · Molecular Therapy · doi:10.1006/mthe.1999.0021 · Cited by 168
Denis-Mize, K. S., Dupuis, M., MacKichan, M. L., Singh, M., Doe, B., O'Hagan, D., Ulmer, J. B., Donnelly, J. J., McDonald, D. M., & Ott, G. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301347 · Cited by 167
Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3
Florea, B. I., Cassará, M. L., Junginger, H. E., & Borchard, G. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00356-5 · Cited by 149
Self-citationEnhanced Gene Expression in Mouse Lung after PEI–DNA Aerosol Delivery
Gautam, A. K., Densmore, C. L., Xu, B., & Waldrep, J. C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0087 · Cited by 121
Influenza vaccines: present and future
Palese, P., & García‐Sastre, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15999 · Cited by 116
Pulmonary cytokine responses associated with PEI–DNA aerosol gene therapy
Gautam, A. K., Densmore, C. L., & Waldrep, J. C. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301369 · Cited by 95
Influenza vaccines: present and future
Palese, P., & García‐Sastre, A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215999 · Cited by 92
Could the airway epithelium play an important role in mucosal immunoglobulin A production?
Salvi, S., & Holgate, S. T. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00644.x · Cited by 90
Current status of gene therapy for lung cancer and head and neck cancer.
Moon, C., Oh, Y. W., & Roth, J. A. (2003) · PubMed · Cited by 75
Wehrlé, P., Magenheim, B., & Benita, S. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 69
Plasmid DNA encapsulation and release from solvent diffusion nanospheres
Hirosue, S., Müller, B. G., Mulligan, R. C., & Langer, R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00353-9 · Cited by 67
Stern, M., Ulrich, K., Geddes, D. M., & Alton, E. W. F. W. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301994 · Cited by 62
Mucosal immunity in the lung and upper airway
Kyd, J. M., Foxwell, A. R., & Cripps, A. W. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00484-9 · Cited by 53
How the SARS vaccine effort can learn from HIV?speeding towards the future, learning from the past
DEGROOT, A. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00489-4 · Cited by 36
Cited by
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Synthesis and characterization of PLGA nanoparticles
Astete, C. E., & Sabliov, C. M. (2006) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856206775997322 · Cited by 776
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer
Morille, M., Passirani, C., Vonarbourg, A., Clavreul, A., & Benoit, J.-P. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.036 · Cited by 769
Development and characterisation of chitosan nanoparticles for siRNA delivery
Katas, H., & Alpar, H. O. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.021 · Cited by 642
Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform
Mandal, B., Bhattacharjee, H., Mittal, N., Sah, H., Balabathula, P., Thoma, L. A., & Wood, G. C. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.11.010 · Cited by 467
Metadata
- Authors
- Bivas-Benita, M., Romeijn, S., Junginger, H. E., & Borchard, G.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 58
- Issue
- 1
- Pages
- 1-6
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2086886701
- Cited by
- 256
- References
- 28
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.